Additionally, recent findings of anti-GRP78 antibodies in NMO and PCD-LEMS have revealed that endothelial targeting antibodies enhance the transmigration of pathogenic IgG (Shimizu et al., 2017, 2019). The gene discussed is HSPA5; the disease is Lambert-Eaton myasthenic syndrome.